Resources - Webinars.jpg

Welcome to The Protein Society Webinar Series

Protein Society webinars deliver timely research reports from experts in protein science. These presentations are free of charge but require prior registration. If an event is over-subscribed, priority will be given to protein society members

Upcoming Webinar - COVID-19: A Protein Science Approach

1280x1280 Webinar - Covid-19.v2.jpg

Please join us on June 4th, 2020  from 12:15-2:45 PM EST as we kick-off our webinar series with our inaugural virtual workshop on COVID-19.  Our expert scientists will share their latest research on coronavirus disease. 

Overview and Introductions: Michael Kay, University of Utah

Research Talks: Rommie Amaro, Debbie Eckert, Nevan Krogan, Jason McLellan

Moderator: Amy Keating, Ph.D., Massachusetts Institute of Technology, President of The Protein Society


Register here. Registration is required; space is limited.


SPEAKERS


Webinars - R Amaro.jpg

Rommie E. Amaro holds the Distinguished Professorship in Theoretical and Computational Chemistry at the Department of Chemistry and Biochemistry at the University of California, San Diego. She received her B.S. in Chemical Engineering (1999) and her Ph.D. in Chemistry (2005) from the University of Illinois at Urbana-Champaign. Rommie was an NIH postdoctoral fellow with Prof. J. Andrew McCammon at UC San Diego from 2005-2009, and started her independent research program in 2009 at the University of California, Irvine. In 2012, Rommie moved her lab to the Department of Chemistry and Biochemistry at the UC San Diego. She is Co-Director of the NIH U01 Drug Design Data Resource, recipient of an NIH New Innovator Award, the Presidential Early Career Award for Scientists and Engineers, the ACS COMP OpenEye Outstanding Junior Faculty Award, the ACS Kavli Foundation Emerging Leader in Chemistry National Lecturer, and the Corwin Hansch Award. Her scientific interests lie at the intersection of computer-aided drug discovery and biophysical simulation. Her scientific vision revolves around expanding the range and complexity of molecular constituents represented in such simulations, development of novel multiscale methods for elucidating their time dependent dynamics, and the discovery of novel chemical matter controlling biological function.
.
Webinars - Debbie Eckert .jpg

Debbie Eckert, Ph.D., is a research associate professor in the Department of Biochemistry at the University of Utah School of Medicine. Her expertise is in developing D-peptide inhibitors of viral entry, using a combination of an innovative enantiomeric screening technology (mirror-image phage display) and structure-guided design. In collaboration with Prof. Michael Kay, she was a key player in the discovery, design, maturation, and preclinical analysis of the HIV D-peptide inhibitor, CPT31, which was recently cleared by the FDA to initiate clinical trials. CPT31 is more potent and broadly neutralizing than the best anti-HIV antibodies and is effective in prevention and treatment protocols in a SHIV rhesus macaque model. Additionally, Dr. Eckert is the Director of the Protein Interactions Core Facility at the University and specializes in the biophysical analyses of proteins and their interaction partners via surface plasmon resonance (SPR), analytical ultracentrifugation (AUC), isothermal calorimetry (ITC), and circular dichroism (CD). Dr. Eckert is also dedicated to the expansion of scientific training access for the disabled community and has established an internship program at the U of Utah for local high school students with disabilities.

.
Webinars - N Krogan.jpg

Nevan Krogan, PhD, is a molecular biologist, UC San Francisco professor, and director of the intensely interdisciplinary Quantitative Biosciences Institute (QBI) under the UCSF School of Pharmacy. He is also a senior investigator at the Gladstone Institutes.

He led the work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG), which includes hundreds of scientists from around the world. His research focuses on developing and using unbiased, quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics. 

Nevan serves as Director of The HARC Center, an NIH-funded collaborative group that focuses on the structural characterization of HIV-human protein complexes. Dr. Krogan is also the co-Director of three Cell Mapping initiatives, the Cancer Cell Mapping Initiative (CCMI), the Host Pathogen Map Initiative (HPMI) and the Psychiatric Cell Map Initiative (PCMI).  These initiatives map the gene and protein networks in healthy and diseased cells with these maps being used to better understand disease and provide novel therapies to fight them.

.
Webinars - J McLellan.jpg

Jason earned a BS in chemistry with an emphasis in biochemistry from Wayne State University in Detroit, Michigan. Afterward, he obtained his PhD from the Johns Hopkins University School of Medicine in Baltimore, Maryland in the laboratory of Dr. Daniel Leahy. He then carried out postdoctoral research at the National Institutes of Health's Vaccine Research Center in the laboratory of Dr. Peter Kwong and in collaboration with Dr. Barney Graham. In the Fall of 2013, he joined the faculty at the Geisel School of Medicine at Dartmouth in the Department of Biochemistry, and in January 2018 he moved his laboratory to the University of Texas at Austin and became a member of the Department of Molecular Biosciences. His lab is interested in elucidating the molecular mechanisms of host–pathogen interactions and leveraging the resulting information for the development of vaccines and immunotherapies.

Boston2021.png